125 computer-programmer-"https:"-"CNR" "https:" "https:" "https:" "https:" "https:" "https:" "Dr" positions at Cedars Sinai Medical Center
Sort by
Refine Your Search
-
(PET)/computed tomography (CT) angiography imaging. As a Postdoctoral Scientist, you will work under the supervision and mentorship of Piotr Slomka, PhD, Director, Innovation in Imaging, Professor in
-
devices and heart failure/transplant clinical research at the Cedars-Sinai Heart Institute (CSHI). In addition to its highly-regarded cardiology program, CSHI is doing groundbreaking work in other important
-
: Completion of postdoctoral scholar training. Demonstrated significant, original or creative contributions to a research project or program. Demonstrated scientific productivity in publications in peer-reviewed
-
(PET)/computed tomography (CT) angiography imaging. As a Postdoctoral Scientist, you will work under the supervision and mentorship of Piotr Slomka, PhD, Director, Innovation in Imaging, Professor in
-
on cell therapy and regenerative medicine. Research conducted in the Rogers Lab stems largely from the pioneering work of Eduardo Marbán, MD, PhD, who mentored Dr. Rogers as a postdoctoral scholar. The
-
management and customer communications Contributes to the digital pathology program within the laboratory to facilitate the next-generation pathology annotation modules. Contributes to the development
-
, to genetics, genomics, neurosciences, and women's health. You can continue your career journey with us! This position offers a collaboration between Dr. Shlomo Melmed and Dr. Cuiqi Zhou. The research focus
-
-level skills to a specific research or creative program. Project Scientists are not required to carry out independent research or to develop an independent research reputation and do not have teaching
-
in close cooperation and in consultation with the Dr. Ruppin and other Research Scientists, the Postdoctoral Scientist will perform routine and complex laboratory procedures throughout training period
-
program. The lab has a strong track record of translating mechanistic bench science—including studies that interrupt signaling between the tumor and host—into clinical trials across multiple cancer types